BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37523980)

  • 1. Activation of Nrf2 inhibits ferroptosis and protects against oxaliplatin-induced ototoxicity.
    Xu K; Chang X; Bai X; Liu HB; Chen XB; Chen HP; Liu YH
    Biomed Pharmacother; 2023 Sep; 165():115248. PubMed ID: 37523980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ferroptosis protects House Ear Institute-Organ of Corti 1 cells and cochlear hair cells from cisplatin-induced ototoxicity.
    Mei H; Zhao L; Li W; Zheng Z; Tang D; Lu X; He Y
    J Cell Mol Med; 2020 Oct; 24(20):12065-12081. PubMed ID: 32929878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferoxamine protects cochlear hair cells and hair cell-like HEI-OC1 cells against tert-butyl hydroperoxide-induced ototoxicity.
    Lu PH; Ma PW; Wang WL; Gao W; Chen JW; Yuan H; Ding XR; Lun YQ; Liang R; Li SY; Wang Z; Guo JN; Mei HK; Lu LJ
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167024. PubMed ID: 38242180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 activation protects auditory hair cells from cisplatin-induced ototoxicity independent on mitochondrial ROS production.
    Zhang W; Xiong H; Pang J; Su Z; Lai L; Lin H; Jian B; He W; Yang H; Zheng Y
    Toxicol Lett; 2020 Oct; 331():1-10. PubMed ID: 32428544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liproxstatin-1 Protects Hair Cell-Like HEI-OC1 Cells and Cochlear Hair Cells against Neomycin Ototoxicity.
    Zheng Z; Tang D; Zhao L; Li W; Han J; Hu B; Nie G; He Y
    Oxid Med Cell Longev; 2020; 2020():1782659. PubMed ID: 33343803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL/6 mice.
    Liu Z; Zhang H; Hong G; Bi X; Hu J; Zhang T; An Y; Guo N; Dong F; Xiao Y; Li W; Zhao X; Chu B; Guo S; Zhang X; Chai R; Fu X
    Mol Ther; 2024 May; 32(5):1387-1406. PubMed ID: 38414247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 Knockout Affected the Ferroptosis Signaling Pathway against Cisplatin-Induced Hair Cell-Like HEI-OC1 Cell Death.
    Wang W; Ma P; Gao W; Lu P; Ding X; Chen J; Yuan H; Lu L
    Oxid Med Cell Longev; 2022; 2022():2210733. PubMed ID: 35814275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferrostatin-1 protects auditory hair cells from cisplatin-induced ototoxicity in vitro and in vivo.
    Hu B; Liu Y; Chen X; Zhao J; Han J; Dong H; Zheng Q; Nie G
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1442-1448. PubMed ID: 33109343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Nrf2 Signalling and the Inhibition of Erastin-Induced Ferroptosis by Ferulic Acid in MIN6 Cells.
    Kose T; Sharp PA; Latunde-Dada GO
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual role of Nrf2/HO-1 pathway in Z-ligustilide-induced ferroptosis against AML cells.
    Chen Z; Zhu Q; Qi X; Yang LR; Rong YX; Wei Q; Wu SQ; Lu QW; Li L; Jiang MD; Qi H
    Phytomedicine; 2024 Feb; 124():155288. PubMed ID: 38183698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol protects hair cells from cisplatin-induced ototoxicity via Nrf2 activation.
    Adachi M; Yanagizono K; Okano Y; Koizumi H; Uemaetomari I; Tabuchi K
    Redox Rep; 2023 Dec; 28(1):2161224. PubMed ID: 36661237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YT521-B homology domain containing 1 ameliorates mitochondrial damage and ferroptosis in sleep deprivation by activating the sirtuin 1/nuclear factor erythroid-derived 2-like 2/heme oxygenase 1 pathway.
    Chen J; Xiao L; Chen Y; Li W; Liu Y; Zhou Y; Tan H
    Brain Res Bull; 2023 Jun; 197():1-12. PubMed ID: 36935054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma.
    Iseda N; Itoh S; Toshida K; Tomiyama T; Morinaga A; Shimokawa M; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Yoshizumi T; Mori M
    Cancer Sci; 2022 Jul; 113(7):2272-2287. PubMed ID: 35466502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperbaric oxygen protects HT22 cells and PC12 cells from damage caused by oxygen-glucose deprivation/reperfusion via the inhibition of Nrf2/System Xc-/GPX4 axis-mediated ferroptosis.
    Chen C; Chen W; Zhou X; Li Y; Pan X; Chen X
    PLoS One; 2022; 17(11):e0276083. PubMed ID: 36355759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loureirin C inhibits ferroptosis after cerebral ischemia reperfusion through regulation of the Nrf2 pathway in mice.
    Liu Y; Mi Y; Wang Y; Meng Q; Xu L; Liu Y; Zhou D; Wang Y; Liang D; Li W; Li N; Hou Y
    Phytomedicine; 2023 May; 113():154729. PubMed ID: 36878093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase.
    Ma W; Hu J; Cheng Y; Wang J; Zhang X; Xu M
    Cancer Chemother Pharmacol; 2015 May; 75(5):949-59. PubMed ID: 25749575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemin mitigates contrast-induced nephropathy by inhibiting ferroptosis via HO-1/Nrf2/GPX4 pathway.
    Gao Z; Zhang Z; Gu D; Li Y; Zhang K; Dong X; Liu L; Zhang J; Chen J; Wu D; Zeng M
    Clin Exp Pharmacol Physiol; 2022 Aug; 49(8):858-870. PubMed ID: 35598290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of copper transporters associated with the ototoxicity induced by platinum-based chemotherapeutic agents.
    Perde-Schrepler M; Fischer-Fodor E; Virag P; Brie I; Cenariu M; Pop C; Valcan A; Gurzau E; Maniu A
    Hear Res; 2020 Mar; 388():107893. PubMed ID: 32006874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.